Thursday, June 17, 2021
Home Citizen News No safety concerns related to the Covishield vaccine trial: Serum chief

No safety concerns related to the Covishield vaccine trial: Serum chief

The phase 2/3 human clinical trial for a vaccine against coronavirus has been running smoothly in the country with no safety concerns so far, and the entire recruitment process of 1,600 volunteers for the Covishield vaccine trial has been completed across 17 trial sites by October 31, according to the Serum Institute of India (SII). Serum Institute, the world’s largest vaccine manufacturer by the number of doses produced, is working on several candidates for a vaccine against Covid-19, including one from AstraZeneca-Oxford University as well as developing its own.

50% LikesVS
50% Dislikes

News Verification For Headline Auditors

If this seems like a news that is relevant to your industry. Would you like to verify the authenticity of the news?
Please Enter your Secret Key

We are building a board of industry expert to help us verify important news stories. If you would like to empanel yourself, please click here.

Report Post

TRENDING NEWS

LATEST NEWS